New findings reveal RG6501 cell therapy shows promising long-term visual improvements for geographic atrophy patients ...

Both dry and wet age-related macular degeneration (AMD) involve changes to the macula, part of the retina in your eye. Dry AMD is more common and involves yellow deposits called drusen, which lead ...

Send comments and news tips to [email protected]. Cite this: Edited by Shrabasti Bhattacharya. Intensive Bevacizumab Boosts Vision in Macular Degeneration - Medscape - June 19, 2025.

A new study suggests that measuring specific immune system proteins in the blood could help predict which patients with intermediate age-related macular degeneration (AMD) are most likely to ...

Disorganization of retinal inner layers (DRIL) is likely an important biomarker signaling visual deterioration in patients with diabetic macular ischemia (DMI), and overall causes for functional ...

Aim To analyse a new grading protocol for clinically significant diabetic macular oedema (CSME) based on spectral domain optical coherence tomography (SD-OCT) and fluorescein angiography (FA). Methods ...

Objective: To investigate the risk of age-related macular degeneration (AMD) in association with optic disc drusen (ODD). Design: Observational, cross-sectional study. Participants: Consecutive ODD ...

Karl Csaky, MD, PhD, shared insights into the relationship between retinal structure and function in dry age-related macular degeneration, focusing on patients with geographic atrophy (GA), at the ...

Source Reference: Shor R, et al "Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration" JAMA Ophthalmol 2025; DOI: 10.1001/jamaophthalmol.2025.1455.

A NEW large-scale cohort study suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), widely prescribed for diabetes and obesity, may significantly increase the risk of neovascular ...

Aims: To investigate the functional implications of macular soft drusen regression in AMD eyes. Methods: Patients were selected from a large ongoing collection of clinical data at Moorfields Eye ...